|
| 3-(4-fluorophenyl)-2-methyl-5-{[(4-methylphenyl)sulfanyl]methyl}pyrazolo[1,5-a]pyrimidin-7(4H)-one |
|
Vibrio |
Stress survival |
Preclinical (in vitro) |
Stanbery L, et al. 2017. Drug Des Devel Ther |
|
| 3-(5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)propan-1-ol |
|
Vibrio |
Post-translational modification |
Preclinical (in vitro) |
Wang G, et al. 2022. ChemMedChem |
|
| 4,4'-[(5,5-Dioxidodibenzo[b,d]thiene-2,8-diyl)bis(oxy)]diphthalonitrile |
|
Vibrio |
VAS T6SS |
Preclinical (in vitro) |
Sun K, et al. 2014. Antimicrob Agents Chemother |
|
| Isonaamine A |
|
Vibrio |
Biofilm |
Preclinical (in vitro) |
Mai T, et al. 2015. Lett Appl Microbiol |
|
| Isonaamine D |
|
Vibrio |
Biofilm |
Preclinical (in vitro) |
Mai T, et al. 2015. Lett Appl Microbiol |
|
| 5-chloro-N-(4-chlorobenzyl)-N-(1,1-dioxidotetrahydrothien-3-yl)-2-(ethylsulfonyl)pyrimidine-4-carboxamide |
|
Vibrio |
Stress survival |
Preclinical (in vitro) |
Stanbery L, et al. 2017. Drug Des Devel Ther |
|
| Isonaamidine A |
|
Vibrio |
Biofilm |
Preclinical (in vitro) |
Mai T, et al. 2015. Lett Appl Microbiol |
|
| Di-isonaamidine A |
|
Vibrio |
Biofilm |
Preclinical (in vitro) |
Mai T, et al. 2015. Lett Appl Microbiol |
|
| Ethyl 4-(3-(2-furyl)-4-(4-hydroxyphenyl)-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate |
|
Vibrio |
Stress survival |
Preclinical (in vitro) |
Stanbery L, et al. 2017. Drug Des Devel Ther |
|
| E676-4861 |
|
Vibrio |
Stress survival |
Preclinical (in vitro) |
Stanbery L, et al. 2017. Drug Des Devel Ther |
|
| | | |
